| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954037 | Journal of the Neurological Sciences | 2018 | 12 Pages |
Abstract
- Common symptoms of Creutzfeld-Jakob disease appeared after lenalidomide was given.
- Discontinuation of lenalidomide improved the patient's cognitive and motor symptoms.
- Three months after discontinuing lenalidomide, she presented with akinetic mutism.
- Diagnosis of sporadic Creutzfeld-Jakob disease was confirmed postmortem.
- Lenalidomide could worsen previous subclinical Creutzfeld-Jakob disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
H. Argente-Escrig, J.C. Martinez, E. Gómez, A. Balaguer, T. Sevilla, L. Bataller,